High, stable and homogenous CD20 expression for efficient rituximab-induced elimination of CD20+ alloreactive donor T cells in the novel CD20/Rituximab 'suicide' system

被引：1
|
作者：
van Meerten, T [1 ]
Claessen, MJ [1 ]
Hagenbeek, A [1 ]
Ebeling, S [1 ]
机构：
[1] Univ Utrecht, Med Ctr, Jordan Lab Hematooncol, Utrecht, Netherlands
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.1750.1750
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1750
引用
收藏
页码：485A / 485A
页数：1
相关论文
共 50 条
  • [41] Modulation of CD20 expression in B-cell lymphomas treated with rituximab.
    Seliem, RM
    Freeman, JK
    Hasserjian, RP
    BLOOD, 2002, 100 (11) : 311B - 311B
  • [42] Decreased CD20 expression in rheumatoid arthritis synovium following rituximab therapy.
    Walsh, Ceara A.
    Fearon, Ursula
    FitzGerald, Oliver
    Veale, Douglas J.
    Bresnihan, Barry
    ARTHRITIS AND RHEUMATISM, 2006, 54 (12): : 4109 - 4109
  • [43] CD20 expression in angioimmunoblastic T cell lymphoma
    Foukas, Periklis G.
    Kefala, Maria
    Papageorgiou, Sotirios
    Tsirigotis, Panagiotis
    Panayiotidis, Panayiotis
    Korkolopoulou, Penelope
    Spathis, Aris
    Dervenoulas, John
    Patsouris, Efstratios
    Karakitsos, Petros
    Panayiotides, Ioannis G.
    LEUKEMIA & LYMPHOMA, 2012, 53 (02) : 345 - 347
  • [44] Preclinical development of the CD20 suicide gene system in T and NK cells.
    Introna, M
    Manganini, M
    Bonamino, M
    Broady, R
    Biondi, A
    Rambaldi, A
    Serafini, M
    BLOOD, 2002, 100 (11) : 650A - 650A
  • [45] Expression of CD20 after viral reactivation renders HIV-reservoir cells susceptible to Rituximab
    Serra-Peinado, Carla
    Grau-Exposito, Judith
    Luque-Ballesteros, Laura
    Astorga-Gamaza, Antonio
    Navarro, Jordi
    Gallego-Rodriguez, Jenny
    Martin, Mario
    Curran, Adria
    Burgos, Joaquin
    Ribera, Esteban
    Raventos, Berta
    Willekens, Rein
    Torrella, Ariadna
    Planas, Bibiana
    Badia, Rosa
    Garcia, Felipe
    Castellvi, Josep
    Genesca, Meritxell
    Falco, Vicenc
    Buzon, Maria J.
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [46] Use of C-terminal deletion mutation of CD20 molecule to predict CD20 expression and time to progression after rituximab in non-Hodgkin lymphoma
    Terui, Y.
    Mishima, Y.
    Yokoyama, M.
    Mishima, Y.
    Takeuchi, K.
    Ito, Y.
    Takahashi, S.
    Hatake, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [47] Expression of CD20 by Adult Neural Progenitor Cells
    Zilkha-Falb, Rina
    Gurevich, Michael
    Achiron, Anat
    NEUROLOGY, 2012, 78
  • [48] Expression of CD20 after viral reactivation renders HIV-reservoir cells susceptible to Rituximab
    Carla Serra-Peinado
    Judith Grau-Expósito
    Laura Luque-Ballesteros
    Antonio Astorga-Gamaza
    Jordi Navarro
    Jenny Gallego-Rodriguez
    Mario Martin
    Adrià Curran
    Joaquin Burgos
    Esteban Ribera
    Berta Raventós
    Rein Willekens
    Ariadna Torrella
    Bibiana Planas
    Rosa Badía
    Felipe Garcia
    Josep Castellví
    Meritxell Genescà
    Vicenç Falcó
    Maria J. Buzon
    Nature Communications, 10
  • [49] Rituximab induced apoptosis "in vitro" on binet a B-CLL; Correlation with CD59/CD20 expression.
    Sarsotti, E
    Terol, MJ
    Benet, I
    Martinez-Climent, JA
    Marugan, I
    Garcia-Conde, J
    BLOOD, 2003, 102 (11) : 861A - 861A
  • [50] Genetic modification of human T cells with CD20: A novel suicide system for the treatment of GVHD.
    Introna, M
    Casati, C
    Bambacioni, F
    Gaipa, G
    Golay, J
    Rambaldi, A
    Biondi, A
    BLOOD, 2000, 96 (11) : 214A - 214A
12345